RT Journal Article
SR Electronic
T1 Risk factors for severe COVID-19 differ by age: a retrospective study of hospitalized adults
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.02.22270287
DO 10.1101/2022.02.02.22270287
A1 Sevda Molani
A1 Patricia V. Hernandez
A1 Ryan T. Roper
A1 Venkata R. Duvvuri
A1 Andrew M. Baumgartner
A1 Jason D. Goldman
A1 Nilüfer Ertekin-Taner
A1 Cory C. Funk
A1 Nathan D. Price
A1 Noa Rappaport
A1 Jennifer J. Hadlock
YR 2022
UL http://medrxiv.org/content/early/2022/02/04/2022.02.02.22270287.abstract
AB Background Risk stratification for hospitalized adults with COVID-19 is essential to inform decisions for individual patients and allocation of potentially scarce resources. So far, risk models for severe COVID outcomes have included age but have not been optimized to best serve the needs of either older or younger adults. Additionally, existing risk models have been limited to either small sample sizes, or modeling mortality over an entire hospital admission. Further, previous models were developed on data from early in the pandemic, before improvements in COVID-19 treatment, the SARS-CoV-2 delta variant, and vaccination. There remains a need for early, accurate identification of patients who may need invasive mechanical ventilation (IMV) or die, considering multiple time horizons.Methods This retrospective study analyzed data from 6,906 hospitalized adults with COVID-19 from a community health system with 51 hospitals and 1085 clinics across five states in the western United States. Risk models were developed to predict mechanical ventilation illness or death across one to 56 days of hospitalization, using clinical data collected available within the first hour after either admission with COVID-19 or a first positive SARS-CoV-2 test. The relative importance of predictive risk factors features for all models was determined using Shapley additive explanations.Findings The percentage of patients who required mechanical ventilation or died within seven days of admission to the hospital due to COVID-19 was 10.82%. For the seven-day interval, models for age ≥ 18 and < 50 years reached AUROC 0.80 (95% CI: 0.70-0.89) and models for age ≥ 50 years reached AUROC 0.83 (95% CI: 0.79-0.88). Models revealed differences in the statistical significance and relative predictive value of risk factors between older and younger patients, including age, BMI, vital signs, and laboratory results. In addition, sex and chronic comorbidities had lower predictive value than vital signs and laboratory results.Interpretation For hospitalized adults, baseline data that is readily available within one hour after hospital admission or a first positive inpatient SARS-CoV-2 test can predict critical illness within one day, and up to 56 days later. Further, the relative importance of risk factors differs between older and younger patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by NIH NIA grant 2U01AG046139-06 (to NDP, NET, and TEG). JJH and VRD have been funded in part with Federal funds from the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, administered by Merck, Inc., on work unrelated to this study. SM and JJH have been funded through Pfizer Inc. Grant No. 68114891 on work unrelated to this study. NET is also funded by NIH NIA R01 AG061796.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics IRB of Institute for Systems Biology gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.